Neeraj Sharma

Array ( [id] => 6220055 [patent_doc_number] => 20100055150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'METHOD AND COMPOSITION FOR TREATMENT OF SKELETAL DYSPLASIAS' [patent_app_type] => utility [patent_app_number] => 12/612645 [patent_app_country] => US [patent_app_date] => 2009-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10968 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055150.pdf [firstpage_image] =>[orig_patent_app_number] => 12612645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6514010 [patent_doc_number] => 20100216709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'SYSTEMIC INSULIN-LIKE GROWTH FACTOR-1 THERAPY REDUCES DIABETIC PERIPHERAL NEUROPATHY AND IMPROVES RENAL FUNCTION IN DIABETIC NEPHROPATHY' [patent_app_type] => utility [patent_app_number] => 12/609115 [patent_app_country] => US [patent_app_date] => 2009-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 13536 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216709.pdf [firstpage_image] =>[orig_patent_app_number] => 12609115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6472035 [patent_doc_number] => 20100041060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'IRON-REGULATING PROTEIN-2(IRP-2) AS A DIAGNOSTIC FOR NEURODEGENERATIVE DISEASE' [patent_app_type] => utility [patent_app_number] => 12/603411 [patent_app_country] => US [patent_app_date] => 2009-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29352 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041060.pdf [firstpage_image] =>[orig_patent_app_number] => 12603411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9951143 [patent_doc_number] => 08999931 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-07 [patent_title] => 'Pharmaceutical composition using gonadotropin-releasing hormone (GNRH) combined variants as immunogen' [patent_app_type] => utility [patent_app_number] => 13/121915 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 7241 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13121915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9823526 [patent_doc_number] => 08933011 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-13 [patent_title] => 'Treatment of preterm labor with toll-like receptor 9 antagonists' [patent_app_type] => utility [patent_app_number] => 13/120605 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17096 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13120605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228856 [patent_doc_number] => 20100183594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'STEROID-SPARING METHODS OF TREATING BRAIN EDEMA' [patent_app_type] => utility [patent_app_number] => 12/560810 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14427 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183594.pdf [firstpage_image] =>[orig_patent_app_number] => 12560810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097447 [patent_doc_number] => 20110003750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'HUMAN 3 RELAXIN' [patent_app_type] => utility [patent_app_number] => 12/538128 [patent_app_country] => US [patent_app_date] => 2009-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15916 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003750.pdf [firstpage_image] =>[orig_patent_app_number] => 12538128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6596826 [patent_doc_number] => 20100292149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Modulation of the Neuroendocrine System as a Therapy for Motor Neuron Disease' [patent_app_type] => utility [patent_app_number] => 12/508908 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12521 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292149.pdf [firstpage_image] =>[orig_patent_app_number] => 12508908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6355207 [patent_doc_number] => 20100022444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'COMBINATION THERAPY FOR MODULATION OF ACTIVITY AND DEVELOPMENT OF CELLS AND TISSUES' [patent_app_type] => utility [patent_app_number] => 12/509160 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17885 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022444.pdf [firstpage_image] =>[orig_patent_app_number] => 12509160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7731435 [patent_doc_number] => 20120014910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING SYMPTOMS ASSOCIATED WITH MENOPAUSE, HORMONAL VARIATIONS AND ARTHRITIS' [patent_app_type] => utility [patent_app_number] => 13/055368 [patent_app_country] => US [patent_app_date] => 2009-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5358 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20120014910.pdf [firstpage_image] =>[orig_patent_app_number] => 13055368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5495480 [patent_doc_number] => 20090263508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => ' MICRONUTRIENT SUPPLEMENT WITH CALCIUM, VITAMIN D OR CALCIUM & VITAMIN D COMBINATION FOR PREMENSTRUAL SYNDROME, POSTPARTUM DEPRESSION, DEPRESSION AND PANIC ATTACKS' [patent_app_type] => utility [patent_app_number] => 12/493559 [patent_app_country] => US [patent_app_date] => 2009-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6840 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263508.pdf [firstpage_image] =>[orig_patent_app_number] => 12493559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220617 [patent_doc_number] => 20100055712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Oligopeptides for treatment of osteoporosis and other bone diseases and methods therefor' [patent_app_type] => utility [patent_app_number] => 12/459060 [patent_app_country] => US [patent_app_date] => 2009-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 10987 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055712.pdf [firstpage_image] =>[orig_patent_app_number] => 12459060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6433843 [patent_doc_number] => 20100278826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Designer Ubiquitin Ligases For Regulation Of Intracellular Pathogenic Proteins' [patent_app_type] => utility [patent_app_number] => 12/481889 [patent_app_country] => US [patent_app_date] => 2009-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 13162 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278826.pdf [firstpage_image] =>[orig_patent_app_number] => 12481889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102577 [patent_doc_number] => 20110166070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'METHOD OF PREVENTING PREMATURE DELIVERY' [patent_app_type] => utility [patent_app_number] => 12/992384 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12984 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166070.pdf [firstpage_image] =>[orig_patent_app_number] => 12992384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320361 [patent_doc_number] => 20100113341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'METHODS OF USING CORTICOTROPIN-RELEASING FACTOR FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/433652 [patent_app_country] => US [patent_app_date] => 2009-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13793 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113341.pdf [firstpage_image] =>[orig_patent_app_number] => 12433652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6377593 [patent_doc_number] => 20100081608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'Use of Human Chorionic Gonadotropin (hCG) by Oral-Sublingual or Injectable Route as an Appetite-Suppressant Agent.' [patent_app_type] => utility [patent_app_number] => 12/430936 [patent_app_country] => US [patent_app_date] => 2009-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2199 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081608.pdf [firstpage_image] =>[orig_patent_app_number] => 12430936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5484946 [patent_doc_number] => 20090274711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'LEVELS OF BLyS/APRIL HETEROTRIMERS IN SERUM AND USE IN DIAGNOSTIC METHODS' [patent_app_type] => utility [patent_app_number] => 12/428146 [patent_app_country] => US [patent_app_date] => 2009-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18114 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274711.pdf [firstpage_image] =>[orig_patent_app_number] => 12428146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6581127 [patent_doc_number] => 20100291079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Heterodimeric Follicle Stimulating Hormone-Fc (FSH-Fc) Fusion Proteins for the Treatment of Infertility' [patent_app_type] => utility [patent_app_number] => 12/427640 [patent_app_country] => US [patent_app_date] => 2009-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15056 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291079.pdf [firstpage_image] =>[orig_patent_app_number] => 12427640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9286222 [patent_doc_number] => 08642551 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Use of liver growth factor (LGF) as a neural tissue regenerator' [patent_app_type] => utility [patent_app_number] => 12/988448 [patent_app_country] => US [patent_app_date] => 2009-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6461 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12988448 [rel_patent_id] =>[rel_patent_doc_number] =>)